Bilal Arif - 04 Mar 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Tech Ops Officer
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Bilal Arif
Issuer symbol
SRPT
Transactions as of
04 Mar 2025
Net transactions value
-$52,089
Form type
4
Filing time
06 Mar 2025, 20:00:08 UTC
Previous filing
04 Mar 2025
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability $28,477 -281 -1.7% $101.34 16,515 04 Mar 2025 Direct F1
transaction SRPT Common Stock Tax liability $23,612 -233 -1.4% $101.34 16,282 04 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.